Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhav R Seshadri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|November 16, 2021
Targeting MALT1 for the treatment of diffuse large B-cell lymphomaMadhav R Seshadri, Ari M Melnick
JACC. Cardiooncology|May 22, 2024
Artificial Intelligence to Complement, Not Replace, Clinical Knowledge: Reading Between the LinesJoshua P Barrios, Madhav R Seshadri, Geoffrey H Tison
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
WBC Growth Factors: ASCO Guideline UpdateBishal Gyawali, Kari Bohlke, Jana K Dickter, et al.
Transplantation and Cellular Therapy|May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyOlalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Leukemia & Lymphoma|August 14, 2025
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agentsSeda S Tolu, Caitlin Gribbin, Zhengming Chen, et al.
American Journal of Hematology|December 23, 2024
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell LymphomaSwetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|November 16, 2021
Targeting MALT1 for the treatment of diffuse large B-cell lymphomaMadhav R Seshadri, Ari M Melnick
JACC. Cardiooncology|May 22, 2024
Artificial Intelligence to Complement, Not Replace, Clinical Knowledge: Reading Between the LinesJoshua P Barrios, Madhav R Seshadri, Geoffrey H Tison
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
WBC Growth Factors: ASCO Guideline UpdateBishal Gyawali, Kari Bohlke, Jana K Dickter, et al.
Transplantation and Cellular Therapy|May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyOlalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Leukemia & Lymphoma|August 14, 2025
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agentsSeda S Tolu, Caitlin Gribbin, Zhengming Chen, et al.
American Journal of Hematology|December 23, 2024
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell LymphomaSwetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, et al.
Pageof 1